Serotonin 6 receptor polymorphism in schizophrenia: frequency, age at onset and cognitive function

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• The serotonin 6 receptor (5HT6) is implicated in schizophrenia due to its limbic region abundance and antipsychotic drug affinity.
• A prior study suggested a link between the 5HT6 gene's C267T polymorphism and schizophrenia susceptibility.

Purpose of the Study:

• To investigate the role of the 5HT6 gene's C267T polymorphism in the pathogenesis of schizophrenia.
• To examine the association between 5HT6 genotypes and age at onset and cognitive function in schizophrenic patients.

Main Methods:

• Genotyping of the 5HT6 C267T polymorphism in 148 schizophrenia patients and 160 healthy controls.
• Assessment of cognitive function using the Mini-Mental State Examination (MMSE) in patients.
• Statistical analysis of genotype and allele frequencies, and correlation with clinical variables.

Main Results:

• No significant differences in 5HT6 genotype or allele frequencies were found between schizophrenia patients and controls.
• The 5HT6 genotypes did not correlate with age at onset or MMSE scores in the patient group.

Conclusions:

• The 5HT6 C267T polymorphism does not appear to be a major factor in schizophrenia susceptibility.
• This polymorphism is not significantly related to cognitive impairment or age at onset in individuals with schizophrenia.
• Further research on 5HT6 gene variations and their impact on schizophrenia symptoms and treatment response is warranted.